CELZ
Creative Medical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 0
Bearish signal 1
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CELZ
Creative Medical Technology Holdings, Inc.
A commercial-stage biotech company that focuses on treating erectile dysfunction and stroke
Biological Technology
12/03/1998
12/03/2021
NASDAQ Stock Exchange
4
12-31
Common stock
211 E Osborn Road, Phoenix, AZ 85012
--
Creative Medical Technology Holdings, Inc., was incorporated in Nevada on December 3, 1998. The company is a commercial-stage biotechnology company dedicated to advancing the identification and translation of novel biological therapies in the fields of immunotherapy, endocrine, urology, neurology and orthopedics.
Company Financials
EPS
CELZ has released its 2025 Q3 earnings. EPS was reported at -0.48, versus the expected -0.63, beating expectations. The chart below visualizes how CELZ has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
